Neuroprotective Agent Improved Outcomes After Acute Ischemic Stroke

(MedPage Today) — NEW ORLEANS — Loberamisal improved functional outcomes after acute ischemic stroke in a placebo-controlled phase III trial, raising its prospects as an investigational neuroprotective therapy.
In patients with relatively…

Source link : https://www.medpagetoday.com/meetingcoverage/isc/119779

Author :

Publish date : 2026-02-06 20:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Neuroprotective Agent Improved Outcomes After Acute Ischemic Stroke

As ICE Uses Medicaid Data, Hospitals Are in a Bind Over Warning Immigrant Patients

Related Posts

As ICE Uses Medicaid Data, Hospitals Are in a Bind Over Warning Immigrant Patients

FDA Updates Risks in Capecitabine, Fluorouracil Labels

FDA Calls for Testing Before Treatment With Widely Used Chemotherapies

Rural America Needs Immigrant Doctors More Than Ever

Intrusive thoughts? John has a room for that

Emails Undermine RFK Jr.’s Testimony on His Trip to Samoa Before a Measles Outbreak

Neuroprotective Agent Improved Outcomes After Acute Ischemic Stroke

As ICE Uses Medicaid Data, Hospitals Are in a Bind Over Warning Immigrant Patients

FDA Updates Risks in Capecitabine, Fluorouracil Labels

FDA Calls for Testing Before Treatment With Widely Used Chemotherapies

Rural America Needs Immigrant Doctors More Than Ever

Intrusive thoughts? John has a room for that

Emails Undermine RFK Jr.’s Testimony on His Trip to Samoa Before a Measles Outbreak

Use of GLP-1 Drugs Under Scrutiny at Winter Olympics

Categories

Archives